...
首页> 外文期刊>Critical care : >Gastric tonometry guided therapy in critical care patients: a systematic review and meta-analysis
【24h】

Gastric tonometry guided therapy in critical care patients: a systematic review and meta-analysis

机译:重症监护患者胃压计引导疗法:系统评价和荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

IntroductionThe value of gastric intramucosal pH (pHi) can be calculated from the tonometrically measured partial pressure of carbon dioxide (PCO2) in the stomach and the arterial bicarbonate content. Low pHi and increase of the difference between gastric mucosal and arterial PCO2 (PCO2 gap) reflect splanchnic hypoperfusion and are good indicators of poor prognosis. Some randomized controlled trials (RCTs) were performed based on the theory that normalizing the low pHi or PCO2 gap could improve the outcomes of critical care patients. However, the conclusions of these RCTs were divergent. Therefore, we performed a systematic review and meta-analysis to assess the effects of this goal directed therapy on patient outcome in Intensive Care Units (ICUs).MethodsWe searched PubMed, EMBASE, the Cochrane Library and ClinicalTrials.gov for randomized controlled trials comparing gastric tonometry guided therapy with control groups. Baseline characteristics of each included RCT were extracted and displayed in a table. We calculated pooled odds ratios (ORs) with 95% confidence intervals (CIs) for dichotomous outcomes. Another measure of effect (risk difference, RD) was used to reassess the effects of gastric tonometry on total mortality. We performed sensitivity analysis for total mortality. Continuous outcomes were presented as standardised mean differences (SMDs) together with 95% CIs.ResultsThe gastric tonometry guided therapy significantly reduced total mortality (OR, 0.732; 95% CI, 0.536 to 0.999, P?=?0.049; I2?=?0%; RD, ?0.056; 95% CI, ?0.109 to ?0.003, P?=?0.038; I2?=?0%) when compared with control groups. However, after excluding the patients with normal pHi on admission, the beneficial effects of this therapy did not exist (OR, 0.736; 95% CI 0.506 to 1.071, P?=?0.109; I2?=?0%). ICU length of stay, hospital length of stay and days intubated were not significantly improved by this therapy.ConclusionsIn critical care patients, gastric tonometry guided therapy can reduce total mortality. Patients with normal pHi on admission contributed to the ultimate result of this outcome; it may indicate that these patients may be more sensitive to this therapy.
机译:简介胃粘膜内pH(pHi)的值可以通过以眼压计测得的胃中二氧化碳(PCO2)分压和动脉碳酸氢盐含量来计算。 pHi低和胃粘膜与动脉PCO2之间的差异(PCO2间隙)增加反映了内脏灌注不足,是预后不良的良好指标。基于以下理论进行了一些随机对照试验(RCT):将低pHi或PCO2缺口归一化可以改善重症监护患者的结局。但是,这些RCT的结论存在分歧。因此,我们进行了系统的回顾和荟萃分析,以评估这种目标导向疗法对重症监护病房(ICU)患者预后的影响。方法我们在PubMed,EMBASE,Cochrane Library和ClinicalTrials.gov上搜索了比较胃癌的随机对照试验。眼压计指导治疗与对照组。提取每个包含的RCT的基线特征并将其显示在表格中。我们计算了二分结果的合并比值比(OR)和95%置信区间(CIs)。另一种效果测量(风险差异,RD)用于重新评估胃压测量对总死亡率的影响。我们进行了总死亡率的敏感性分析。结果以标准均数差(SMD)和95%CI表示连续结果。胃压术指导治疗显着降低总死亡率(OR为0.732; 95%CI为0.536至0.999,P <= 0.049; I2 == 0与对照组相比,%; RD,≤0.056; 95%CI,≤0.109至≤0.003,P≤= 0.038;I2≤= 0%。但是,在排除pHi正常的患者入院后,这种治疗的益处并不存在(OR,0.736; 95%CI 0.506至1.071,P <= 0.1901; I2 == 0%)。 ICU住院时间,住院时间和插管天数没有明显改善。结论在重症监护患者中,胃压计指导治疗可以降低总死亡率。入院时pHi正常的患者为这一结果的最终结果做出了贡献。这可能表明这些患者可能对该疗法更敏感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号